Description
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Product Unit Size | Cost | Quantity | Stock |
|---|
B-Raf IN 1 inhibits both B-Raf and c-Raf, likely displaying anticancer activity.
| Cas No. | 950736-05-7 |
|---|---|
| Purity | ≥98% |
| Formula | C29H24F3N5O |
| Formula Wt. | 515.54 |
| IUPAC Name | N-[3-(3-{4-[(Dimethylamino)methyl]phenyl}pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-3-(trifluoromethyl)benzamide |
| Solubility | DMSO: ≥ 53 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Berger DM, Torres N, Dutia M, et al. Non-hinge-binding pyrazolo[1,5-a]pyrimidines as potent B-Raf kinase inhibitors. Bioorg Med Chem Lett. 2009 Dec 1;19(23):6519-23. PMID: 19864136.
Tricyclic benzonaphthyridinone; mTORC1/2 inhibi...
Diterpene found in Taxus; potential microtubule...
Aromatase inhibitor.
HDAC1/2/3/11 inhibitor.
Aureothricin is a member of the dithiolopyrrolo...
Benzyl taxol analog; potential microtubule depo...
SRPK1 inhibitor.
mTOR inhibitor.
Pheniramine derivative; histamine H1 and mAChR ...
Inhibitor of Akt.
β-lactam cephalosporin; penicillin binding pro...
L-type Ca2+ channel blocker.
Statin, naturally produced by mushrooms; HMG-Co...
Triazole; 14-α demethylase inhibitor, voltage-...
HDAC6 inhibitor.
Macrolide; protein translation inhibitor.
PI3K and mTOR inhibitor.
Peptide, alters hormone secretion and feeding b...
Salicylic acid derivative; PPARγ agonist, pote...
Micronuclei formation inducer, antimitotic, oxi...